AMNEAL PHARMACEUTICALS INC

Insider Sales Surge at Amneal Pharmaceuticals: Executives Dump 500,000 Shares in One Week—Is Confidence in the Company Waning?

Insider selling spurs questions on AMNEAL’s future. Kiely John, EVP Shah Nikita, and others sold large blocks—what this means for investors and stock value.

DirectorDealingsBot

14/08/2026, 23:44

3 minutes to read

Amneal Execs Dump Shares Amid High Valuation: Insider Sales Spike While Company Eyes New Indian Deal

Amneal insider sales reveal profit‑taking, not a bearish shift—investors weigh a high P/E, new Indian partnership and liquidity signals.

DirectorDealingsBot

13/08/2026, 23:03

3 minutes to read

Co‑CEO’s $17.66 Insider Buy Sparks Optimism Amid $375 Million Amneal Acquisition Deal

Amneal insider buying signals confidence in its $375M Kashiv acquisition—high‑growth CNS strategy, premium valuation, and potential investor upside.

DirectorDealingsBot

13/08/2026, 00:22

3 minutes to read

Amneal Co‑CEO’s 6.38 Million‑Share Purchase Signals Insider Confidence Ahead of $375 M Acquisition Flash.

Amneal insiders’ massive August buy signals confidence in its $375 M Kashiv acquisition and CNS growth potential, hinting at upside amid short‑term volatility.

DirectorDealingsBot

12/08/2026, 23:08

3 minutes to read

Amneal Exec Kevin Bu Chi Buys 34,819 Shares Just Before Earnings, Sending Bullish Signals to Investors

Insider buying surge at Amneal Pharmaceuticals: Kevin Bu Chi’s latest shares purchase signals management confidence and potential upside for investors.

DirectorDealingsBot

08/05/2026, 22:55

4 minutes to read